Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 12Active not recruiting 5Recruiting 2Unknown 1

Sponsor Class

OTHER 42INDUSTRY 22NETWORK 5NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Breast Neoplasms 2Endometrial Neoplasms 1Cystadenocarcinoma, Serous 1Breast Neoplasms, Male 1Breast Neoplasm Female 1

Interventions

Specimen Handling 18Cyclophosphamide 17Magnetic Resonance Spectroscopy 16Dexamethasone 15Cisplatin 14Vincristine 13Radiotherapy 13Radiation 11Etoposide 10Carboplatin 10durvalumab 9Radiotherapy, Intensity-Modulated 9Paclitaxel 9Doxorubicin 8Cytarabine 8Temozolomide 7Rituximab 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6tremelimumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Letrozole × Clear all
NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Borstkanker Onderzoek Groep

Phase 3 Active not recruiting
1,050 enrolled
Breast

Breast Neoplasm Female

NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

GOG Foundation

Phase 2 Active not recruiting
53 enrolled
Gynecologic

Endometrial Neoplasms

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03673124 2025-12-23

Ribociclib and Letrozole Treatment in Ovarian Cancer

GOG Foundation

Phase 2 Active not recruiting
51 enrolled 19 charts

Cystadenocarcinoma, Serous

NCT03283384 2025-09-19

NEOLBC

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡